In this issue of JAMA Internal Medicine, the article by Judge-Golden et al1 provides further evidence that dispensing a larger supply of contraception is cost-effective. This economic decision model explored the financial implications for the Veteran Affairs (VA) health care system of offering beneficiaries 12 months of oral contraceptive pills (OCPs) in a single prescription. Across a range of sensitivity analyses, the authors found that the 12-month dispensing option was cost saving to the VA compared with the standard 3-month dispensing option, largely owing to the reduction in unintended pregnancy.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Grossman D. Expanding Access to Short-Acting Hormonal Contraceptive Methods in the United States. JAMA Intern Med. Published online July 08, 2019179(9):1209–1210. doi:10.1001/jamainternmed.2019.1676
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: